# 68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

> **NCT05902377** · PHASE2 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 46 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-NY104 PET/CT

## Key facts

- **NCT ID:** NCT05902377
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05902377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05902377, "68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05902377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*